"Every sucess is the mother of countless others"

Henry Ford

In-/Out-Licensing

Natural surfactant for prevention and treatment of IRDS

Natural surfactant for the treatment of RDS

Active ingredient

- Phospholipid fraction from bovine lungs

Use

- Prevention of respiratory distress syndrome (RDS) in premature infants

- Treatment of infantile respiratory distress syndrome (IRDS)

Pharmaceutical form and presentations

- Lyophilized phospholipids in vials with 50 mg and 100 mg

- Syringe with solvent for reconstitution

Application

- Intratracheal instillation

Special feature

- Storage at room temperature

Produced in

- European Union

Available countries

- On request

 

Regulatory status, indications and product information may vary from country to country.

Product descriptions provide basic information and are not usage instructions.

Please observe the officially approved product information.